Industry News
Moderna announces strategy to address Omicron SARS-CoV-2 variant
Company testing three existing COVID-19 vaccine booster candidates against the Omicron variant
Company testing three existing COVID-19 vaccine booster candidates against the Omicron variant
Agreement to leverage manufacturing capacity to continue to drive global supply of vaccines